Moreover, miR‐142, that is related to radiosensitivity and acts as a tumor suppressor in HR + BC (Mansoori et al., 2019), was downregulated in patients with Grade III of differentiation and p53 positive. The gene discussed is TP53; the disease is breast cancer.